Arrakis Therapeutics, Inc. — Form D
Arrakis Therapeutics, Inc. of Waltham, MA, a company, filed a Form D exempt-offering notice with the SEC on 2017-03-02. The offering totals $41.2M, of which $13.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2017-03-02
- Form: D
- Accession: 0001699493-17-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $41.2M
- Amount sold: $13.2M
- Remaining: $28.0M
- Investors: 8
- Date of first sale: 2017-02-15
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-281666
Issuer
- Name: Arrakis Therapeutics, Inc.
- CIK: 0001699493
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 830 Winter Street 830 Winter Street, Waltham, MA, 02451
- Phone: 857-488-4488
Officers, directors & promoters (18)
| Name | Role | Location |
|---|
| Colleen E Cuffaro | Director | Cambridge, MA |
| Carolyn E Green | Director | Cambridge, MA |
| Alan E Walts | Director | Cambridge, MA |
| David E Neafus | Executive Officer | Cambridge, MA |
| Russell C Petter | Executive Officer | Cambridge, MA |
| Nikola Trbovic | Director | Waltham, MA |
| Nikola Trbovic | Related Person | Waltham, MA |
| Michael Gilman | Director | Waltham, MA |
| Michael Gilman | Executive Officer | Waltham, MA |
| Michael Gilman | Related Person | Waltham, MA |
| Raj Parekh | Director | Waltham, MA |
| Raj Parekh | Related Person | Waltham, MA |
| Richard Gaster | Director | Waltham, MA |
| Richard Gaster | Related Person | Waltham, MA |
| Jakob Loven | Director | Waltham, MA |
| Jakob Loven | Related Person | Waltham, MA |
| Colleen Cuffaro | Director | Waltham, MA |
| Colleen Cuffaro | Related Person | Waltham, MA |
Other filings by this issuer (1)
More